ACME Laboratories Ltd IPO Lottery Result 2016 Information. ACME Laboratories Limited IPO Result 2016. The ACME Laboratories Ltd is set to raise capital from institutional and individual investors using the book-building method, a widely used initial public offering (IPO) mechanism. The five crore ordinary shares of Tk 10 each will be offloaded through used initial public offering system, and the raised funds will be used for setting up three new plants at Dhamrai in Savar, said Md Zahangir Alam, chief financial officer of Acme Laboratories.
ACME Laboratories IPO Result
ICB Capital Management is the issue manager of the company while Prime Capital Management is the registrar to the issue.
Acme Laboratories is the third firm to
use the book-building system after the stockmarket regulator modified
the pricing rules following the market crash of 2011.
As per newly amended public issue rules
Bangladesh Securities Exchange Commission (BSEC) approved to offer
ACME’s of the 5 crore IPO shares, 2.50 crore will be allocated for EIIs
worth Tk. 2,130.00 million, 50 lac for mutual fund worth Tk.426.00
million and rest 2 crore shares will be offered to the general, affected
and NRB investors worth Tk. 1540.00 million.
[Result available now]
Acme Laboratories Ipo Lottery Result
ACME Laboratories Ltd Ipo Result will be available in our website. You can easily download you result from our website as well as Dhaka Stock Exchange official website.
| Title | Download |
|---|---|
|
Stock Exchange TREC No. / M.Bank SL No.
|
|
|
Residents Bangladeshi
|
|
|
Residents Bangladeshi affected small investors
|
|
|
Non-Residents Bangladeshi
|
|
|
Mutual Fund (Pro-rata Allotment)
|
[Result available now]
ACME Laboratories will use the IPO fund (Tk. 4,096.00 million) in implementing three new projects and to meet from IPO proceeds.
Nos. Of share offer for eii: 25,000,000
Nos. Of share offer for mutual fund: 5,000,000 nos.
Of share offer for individual investors: 20,000,000
Total value of ipo: tk. 4,096,000,000/=
Individual investors ipo value: tk. 1,540,000,000/=
ACME Laboratories IPO Subscription details:
The country’s oldest pharmaceutical
company, ACME Laboratories Subscription opens from 11th April 2016 and
close 21st April 2016.
Subscription open: 11 Apr 2016
Subscription close: 21 Apr 2016
Subscription close for NRB: 11 Apr 2016 to 21 Apr 2016
- Offer price 77.0
- Face value per share 10.0
- Market lot 100 units
- Single lot price 7700.0
The Company’s last five years
(01-07-2010 to 30-06-2015) weighted average earning per shares (EPS) was
Tk. 4.07 and Tk. 5.70 for the year ended on 30 June 2015. Net Assets
Value (NAV) per share is Tk. 70.37 for the year ended on 30 June 2015.
The ACME Laboratories Ltd. is a leading
company for manufacturing world-class and top-quality pharmaceutical
products in Bangladesh. Through the outstanding knowledge,
professionalism and commitment of more than 7,000 employees, then are
consistently building upon our facilities, capabilities and also
portfolio to meet the growing health care needs.
The pharmaceutical sector is now one of
the fastest growing sectors in the country, with its average growth rate
coming to 17.2 percent over the last five years and 13.1 percent over
the last decade.
Acme Laboratories Limited Address:
| ACME’s modernized plant is located at Dhamrai, about 40 km N.W. of Dhaka, the capital of Bangladesh.
Plant Address: Dhamrai, Dhaka, Bangladesh Phone: +88 02 7730142, +88 02 7730816-7, +88 02 7730881-2 Fax: +88 02 7730141 Email: plant@acmeglobal.com |
Corporate Office: ACME Laboratories Limited Court de la ACME
1/4, Mirpur Road, Kallayanpur, Dhaka 1207, Bangladesh. Phone: +88 02 9004194-6, +88 02 9005620 Fax: +88 02 9016872, +88 02 9032475, +88 02 9016515 Email:headoffice@acmeglobal.com |
Web Address: www.acmeglobal.com
If you need more
information about ACME Laboratories Ltd IPO Result & Application
detials then comment below of message us through facebook to get fast
response. We will update all IPO result information in our website.
ACME Laboratories Ltd IPO Lottery Result 2016
Advertisement
0 comments: